Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Moscow Exchange reported for 3rd quarter of 2025 under IFRS

11/26/25 MOEX

NKHP reported for 9 months of 2025 under RAS

11/25/25 NKHP

Kamaz lowered its sales forecast in 2025

11/25/25 KMAZ

Svetofor Driving School reported for 9 months of 2025 under RAS

11/25/25 SVET

Board of Directors of Ozon Pharmaceuticals recommended dividends

11/25/25 OZPH

O'Key Group completes sale of hypermarkets to management

11/25/25 OKEY

Sovcomflot commissioned tanker Ivan Aivazovsky

11/25/25 FLOT

Gazprom and CNPC have started the design and construction of a gas pipeline across the Ussuri River

11/25/25 GAZP

Nauka-Svyaz reported for 9 months of 2025 under IFRS

11/25/25 NSVZ

Abrau-Durso harvests record grapes

11/25/25 ABRD